CUSIP No. 852312305
13G
Page 2 of 10 Pages
1.
NAMES OF REPORTING PERSONS OR
I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS (ENTITIES ONLY)
Patrick Lee, MD
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a) [ ]
(b) [ x ]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
USA
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
3,778,938
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
3,778,938
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,778,938
10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) [ ]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
8.47%
12.
TYPE OF REPORTING PERSON (see instructions)
IN, HC
CUSIP No. 852312305
13G
Page 3 of 10 Pages
1.
NAMES OF REPORTING PERSONS OR
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Anthony Joonkyoo Yun, MD
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a) [ ]
(b) [ x ]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
USA
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
3,778,938
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
3,778,938
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,778,938
10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) [ ]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
8.47%
12.
TYPE OF REPORTING PERSON (see instructions)
IN, HC
CUSIP No. 852312305
13G
Page 4 of 10 Pages
1.
NAMES OF REPORTING PERSONS OR
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Palo Alto Investors LP
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a) [ ]
(b) [ x ]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
California
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
3,778,938
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
3,778,938
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,778,938
10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) [ ]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
8.47%
12.
TYPE OF REPORTING PERSON (see instructions)
OO, IA
CUSIP No. 852312305
13G
Page 5 of 10 Pages
1.
NAMES OF REPORTING PERSONS OR
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
PAI LLC
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a) [ ]
(b) [ x ]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
California
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
3,778,938
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
3,778,938
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,778,938
10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) [ ]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
8.47%
12.
TYPE OF REPORTING PERSON (see instructions)
OO, IA
CUSIP No. 852312305
13G
Page 6 of 10 Pages
Item 1.
(a)
Name of Issuer
STAAR Surgical Company
(b)
Address of Issuers Principal Executive Offices
1911 Walker Avenue, Monrovia, CA 91016
Item 2.
(a)
Name of Person Filing
Palo Alto Investors LP ("PAI")
PAI LLC (PAI GP)
Patrick Lee, MD
Anthony Joonkyoo Yun, MD
(collectively, the "Filers").
(b)
The address of the principal place of the Filers is located at:
470 University Avenue, Palo Alto, CA 94301
(c)
For citizenship of Filers, see Item 4 of the cover sheet for each Filer.
(d)
Title of Class of Securities
Common Stock
(e)
CUSIP Number
852312305
Item 3. If this statement is filed pursuant to 240.13d-1(b) or
240.13d-2(b) or (c), check whether the person filing is a:
(a)
[ ]
Broker or dealer registered under section 15 of
the Act (15 U.S.C. 78o).
(b)
[ ]
Bank as defined in section 3(a)(6) of the
Act (15 U.S.C. 78c).
(c)
[ ]
Insurance company as defined in section 3(a)(19) of
the Act (15 U.S.C. 78c).
(d)
[ ]
Investment company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e)
[x]
An investment adviser in accordance
with 240.13d-1(b)(1)(ii)(E);
(as to PAI)
CUSIP No. 852312305
13G
Page 7 of 10 Pages
(f)
[ ]
An employee benefit plan or endowment fund
in accordance with 240.13d-1(b)(1)(ii)(F);
(g)
[x]
A parent holding company or control person in
accordance with 240.13d-1(b)(1)(ii)(G);
(as to Dr. Lee and Dr. Yun)
(h)
[ ]
A savings associations as defined in Section 3(b)
of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
[ ]
A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the
Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
[ ]
Group, in accordance with 240.13d-1(b)(1)(ii)(J).
CUSIP No. 852312305
13G
Page 8 of 10 Pages
Item 4. Ownership.
See Items 5-9 and 11 of the cover page for
each Filer. The number of shares held by the
Filers includes (1) Common Stock that they
hold directly and (2) Common Stock that they
may acquire on conversion of shares of the
Companys Series A Convertible Preferred Stock
(Series A Preferred) that they hold.
Shares of Common Stock are held by Healthcare
Master and Healthcare Master II.
Item 5. Ownership of Five Percent or Less of a Class.
N/A
Item 6. Ownership of More than Five Percent on Behalf
of Another Person.
PAI is a registered investment adviser and investment
adviser of investment limited partnerships, and is
the investment adviser to other investment funds.
PAI GP is the general partner of investment
limited partnerships. PAIs clients have
the right to receive or the power
to direct the receipt of dividends
from, or the proceeds from the
sale of, the Stock.
Item 7. Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on By the
Parent Holding Company.
N/A
Item 8. Identification and Classification of Members of the Group.
Dr. Lee and Dr. Yun co-manage PAI. The Filers are
filing this Schedule 13G jointly, but not as
members of a group, and each of them expressly disclaims
membership in a group. Each Filer disclaims beneficial o
wnership of the Stock except to the extent of that Filers
pecuniary interest therein.
Item 9. Notice of Dissolution of Group.
N/A
CUSIP No. 852312305
13G
Page 9 of 10 Pages
Item 10. Certification.
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired
and are not held for the purpose of or with the effect of changing
or influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
Exhibits.
Exhibit A Joint Filing Agreement.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is
true, complete and correct.
Dated: February 14, 2020
PALO ALTO INVESTORS LP
By: /s/ Angela Nguyen-Dinh, Chief Compliance Officer
PAI LLC
By: /s/ Patrick Lee, MD
/s/ Patrick Lee, MD
/s/ Anthony Joonkyoo Yun, MD
CUSIP No. 852312305
13G
Page 10 of 10 Pages
EXHIBIT A
AGREEMENT REGARDING JOINT FILING
OF STATEMENT ON SCHEDULE 13D OR 13G
The undersigned agree to file jointly with the Securities and
Exchange Commission (the "SEC") any and all statements on
Schedule 13D or Schedule 13G (and any amendments or supplements
thereto) required under section 13(d) of the Securities Exchange
Act of 1934, as amended, in connection with purchases and sales
by the undersigned of the securities of any issuer until such
time as the undersigned file with the SEC a statement terminating
this Agreement Regarding Joint Filing of Statement on Schedule
13D or 13G. For that purpose, the undersigned hereby constitute
and appoint Palo Alto Investors, LP, a California limited partnership,
as their true and lawful agent and attorney-in-fact, with full power
and authority for and on behalf of the undersigned to prepare or
cause to be prepared, sign, file with the SEC and furnish to any
other person all certificates, instruments, agreements and documents
necessary to comply with section 13(d) and section 16(a) of the
Securities Exchange Act of 1934, as amended, in connection with
said purchases and sales, and to do and perform every act
necessary and proper to be done incident to the exercise of
the foregoing power, as fully as the undersigned might or
could do if personally present, until such time as the undersigned
file with the SEC a statement terminating this Agreement Regarding
Joint Filing of Statement on Schedule 13D or 13G.
Dated: February 14, 2020
PALO ALTO INVESTORS LP
By: /s/ Angela Nguyen-Dinh, Chief Compliance Officer
PAI LLC
By: /s/ Patrick Lee, MD
/s/ Patrick Lee, MD
/s/ Anthony Joonkyoo Yun, MD
|